You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site. 

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

Arjo-Vascular-Therapy-VTE-Prevention-Pumps-TRIPULSE_02_V2_RET.jpg

VTE prevention pumps

VTE prevention pumps

IPC pumps and garments provide a safe and effective method of preventing Venous Thromboembolism (VTE) by replicating what the body does naturally.

 

VTE is a disease that includes both Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

IPC pumps help to mitigate not one, but two of the risk factors associated with VTE development: venous stasis and hypercoagulability.

The inflation-deflation cycle of IPC therapy  simulates the thigh, calf and foot's normal ambulatory pump action increasing  both the volume and rate of blood flow,eliminating venous stasis and replicating  the effects of the natural muscle pump(1).

This benefits non-ambulatory patients by:

  • decreasing venous hypertension; 
  • flushing valve pockets where thrombi are thought to have originated; and 
  • decreasing interstitial oedema(2).

IPC delivers the dual hematological benefits of suppressing pro-coagulant activation and enhancing global fibrinolysis(3).

This mechanical method of VTE prevention presents no risk of bleeding and can be used to complement pharmacological methods to increase effectiveness in high risk patients. The well established and globally recognised Flowtron® brand has been steadily evolving over the past 30 years, providing effective VTE prevention products.

During this time a number of independent international clinical studies have compared Arjo Flowtron VTE prophylaxis systems with other VTE prevention methods: Results show that Flowtron IPC therapy provides a cost effective VTE prevention method, while avoiding side effects such as bleeding.

Clinical studies of Arjo Flowtron IPC systems for VTE prevention have consistently resulted in low occurences of DVT in high risk groups(4).

References

1. Morris RJ, Woodcock JP (2004). Evidenced based compression: prevention of stasis and deep vein thrombosis. Annals of Surgery; 239(2): 162-171.

2. Kumar S, Walker M. The effects of intermittent pneumatic compression on the arterial and venous system of the lower limb: a review. Journal of Tissue Viability. 2002; 12(2): 58-65.

3. Morris RJ, Giddings JC, Ralis HM, Jennings GM, Davies DA et al (2006). The influence of inflation rate on the hematologic and hemodynamic effects of intermittent pneumatic compression for deep vein thrombosis prophylaxis. Journal of Vascular Surgery; 44(5): 1039-1045.

4. DVT rate collated from published results relating to Flowtron studies, including blood flow, fibrinolytic and compliance studies: 1992-2007.

 

Flowtron Universal

Read more about

Flowtron Excel

Read more about

Flowtron ACS800 with TriPulse

Read more about

Flowtron ACS 900

Read more about